These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7341714)

  • 1. [Is Cox's theory applicable to cancer survival analysis? (author's transl)].
    Maetani S; Maruoka Y; Tobe T; Kashiwara S; Kuramoto S
    Nihon Gan Chiryo Gakkai Shi; 1981 Dec; 16(7):1377-83. PubMed ID: 7341714
    [No Abstract]   [Full Text] [Related]  

  • 2. [Estimation of survival rates: technics used (author's transl)].
    Rodary C; Laplanche A; Comnougue C; Flamant R
    Bull Cancer; 1979; 66(5):575-80. PubMed ID: 554686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Cox's and relative survival models when estimating the effects of prognostic factors on disease-specific mortality: a simulation study under proportional excess hazards.
    Le Teuff G; Abrahamowicz M; Bolard P; Quantin C
    Stat Med; 2005 Dec; 24(24):3887-909. PubMed ID: 16320267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Decision theory and significance of prophylactic postoperative irradiation for primary lung cancer. Part II. Analysis by linear discriminant function (author's transl)].
    Odano I
    Nihon Igaku Hoshasen Gakkai Zasshi; 1979 Aug; 39(8):848-52. PubMed ID: 503805
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biorhythm theory and primary irradiation of inoperable cancer of the cervix (author's transl)].
    Kucera H; Riss P; Weghaupt K
    Strahlentherapie; 1980 Jul; 156(7):453-6. PubMed ID: 6162251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Survival of cancer patients diagnosed in a cancer center--the Center for Adult Diseases, Osaka (author's transl)].
    Hanai A; Fujimoto I; Taniguchi H
    Nihon Gan Chiryo Gakkai Shi; 1979 Dec; 14(7):1093-105. PubMed ID: 541535
    [No Abstract]   [Full Text] [Related]  

  • 7. Applying Cox regression to competing risks.
    Lunn M; McNeil D
    Biometrics; 1995 Jun; 51(2):524-32. PubMed ID: 7662841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Editorial: Oncology: duration and quality of survival (author's transl)].
    Pettavel J
    Schweiz Rundsch Med Prax; 1975 Nov; 64(46):1465-6. PubMed ID: 1215303
    [No Abstract]   [Full Text] [Related]  

  • 9. [New methods for measurement and comparison of survival rates of neoplasms and immunization results (author's transl)].
    Tang DL
    Zhonghua Yu Fang Yi Xue Za Zhi; 1980 Aug; 14(3):150-5. PubMed ID: 7472053
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long survival periods after therapy for metastatic or reccurrent cancer (author's transl)].
    Israel L; Depierre A
    Sem Hop; 1978 Dec 8-15; 54(43-44):1382-4. PubMed ID: 219495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of mathematical optimization in radiation therapy for finding optimum irradiation techniques (author's transl)].
    Franke DS
    Radiobiol Radiother (Berl); 1980 Oct; 21(5):668-76. PubMed ID: 7208855
    [No Abstract]   [Full Text] [Related]  

  • 12. [What is the explanation for the higher cancer death rate in large cities? (author's transl)].
    Fassl H
    Offentl Gesundheitswes; 1977 Aug; 39(8):495-8. PubMed ID: 143630
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biological systems and systems theory (5) (author's transl)].
    Furukawa T; Kajiya F
    Iyodenshi To Seitai Kogaku; 1977 Sep; 15(5):345-50. PubMed ID: 592550
    [No Abstract]   [Full Text] [Related]  

  • 14. [Background radiation and childhood cancer mortality (author's transl)].
    Sakka M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1979 May; 39(5):536-9. PubMed ID: 482073
    [No Abstract]   [Full Text] [Related]  

  • 15. [Analysits of 5-year survival in radiotherapy of malignant tumors (author's transl)].
    Ashizawa A; Nakashima A; Mori H; Matsunaga N; Mutsukura M
    Rinsho Hoshasen; 1979 Aug; 24(8):861-6. PubMed ID: 529467
    [No Abstract]   [Full Text] [Related]  

  • 16. [The prospective estimation of cancer treatment (author's transl)].
    Kumasawa A; Iino Y
    Nihon Gan Chiryo Gakkai Shi; 1980 Dec; 15(7):1104-8. PubMed ID: 7229468
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cancer control (author's transl)].
    Oeser H; Koch HC; Rach K
    MMW Munch Med Wochenschr; 1976 Jul; 118(31):961-6. PubMed ID: 822284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiology of cancer (author's transl)].
    Pawlega J
    Przegl Lek; 1981; 38(5):447-51. PubMed ID: 7268044
    [No Abstract]   [Full Text] [Related]  

  • 19. An analysis of survival curves of patients with selected cancers: use of the "half-life" concept in cancer survival statistics.
    Mueller CB; Sullivan H; Ratz W
    Br J Surg; 1969 Aug; 56(8):625. PubMed ID: 5797762
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of hypertrophy and dilatation on the left ventricular pressure-volume relation---analysis based on the large deformation theory (author's transl)].
    Nakamura T; Kosaka S; Asoo N; Kimura T; Motomiya M; Konno K; Suzuki N; Abe H; Arai S
    Iyodenshi To Seitai Kogaku; 1978 Feb; 16(1):39-44. PubMed ID: 149210
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.